30 November 2021 - Lilly Canada is pleased to announce the completion of a successful negotiation with the pan-Canadian Pharmaceutical Alliance that will broaden access for Baqsimi, an important emergency rescue treatment.

The successful negotiation and the completed letter of intent is the first step toward public access for Baqsimi. Lilly will now work with the various provinces and territories to finalise details for regional access to this rescue medication.

Read Eli Lilly press release